Timetable
Subject to change
Thursday, September 7, 2023
|
||
| Hall A |
Hall B | |
| 16:00 – 17:45 | Pre-Congress Industry Symposium | |
| 18:30 – 21:00 | Dinner Symposium | |
Friday, September 8, 2023
|
||
| Hall A |
Hall B |
|
| 08:45 – 09:00 | Congress opening |
|
| 09:00 – 10:00 | Plenary Session 1: Neoadjuvant therapy: HER2 negative/positive What to do after neoadjuvant |
|
| 10:00 – 11:00 | Plenary Session 2: Adjuvant endocrine therapy |
|
| 11:00 – 11:30 | Coffee break and poster viewing | |
| 11:30 – 12:30 | Session 3: Tumour Board: Early disease |
Session 4: Surgical |
| 12:30 – 13:30 | Lunch Break and poster viewing | |
| 12:45 – 13:30 | Session 5: Lunch symposium |
|
| 13:30 – 14:30 | Session 6: Surgical |
|
| 14:30 – 15:30 | Session 7: Advanced triple negative disease |
Session 8: Imaging/Surgical |
| 15:30 – 16:00 | Coffee break and poster viewing | |
| 16:00 – 17:00 | Session 9: Tumour Board |
|
Saturday, September 9, 2023
|
||
| Hall A |
Hall B |
|
| 09:00 – 10:00 | Session 10: HER2 low breast cancer |
Session 11: Free papers |
| 10:00 – 11:00 | Plenary Session 12: Oligometastatic disease |
|
| 11:00 – 11:30 | Coffee break and poster viewing | |
| 11:30 – 12:30 | Session 13: Localisation |
Session 14: Lunch symposium |
| 12:30 – 13:30 | Lunch Break and Poster Viewing | |
| 13:30 – 14:30 | Session 15: Who gets chosen for molecular testing |
Session 16: Free papers |
| 14:30 – 15:30 | Session 17: Breast cancer 2030 |
|
| 15:30 – 15:45 | Congress closing and award presentation | |